New antibody therapy shows promise in combating kidney transplant rejection

Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term.

Related Keywords

Austria ,Vienna ,Wien ,Berlin ,Germany ,Canada ,Katharina Mayer ,Klemens Budde ,Department Of Clinical Pharmacology Bernd Jilma ,University Of Vienna ,Department Of Medicine ,Clinical Division Of Nephrology ,University Of Alberta ,University Hospital Vienna ,University Hospital Basel ,Clinical Division ,Meduni Vienna ,England Journal ,Clinical Pharmacology ,Bernd Jilma ,Human Immunology Biosciences ,